The RenTg mice: a powerful tool to study renin-dependent chronic kidney disease

Anne-Cecile Huby1, Panagiotis Kavvadas, Carlo Alfieri

  • 1Institut National de la Santé et de la Recherche Médicale Joint Research Unit S 702, Batiment Recherche, Tenon Hospital, Paris, France.

Plos One
|January 10, 2013
PubMed
Abstract

Insights

A novel mouse model (RenTg) progressively develops chronic kidney disease (CKD) mimicking human pathology. This model reveals early endothelial dysfunction preceding structural damage, offering insights into CKD progression.

Area of Science:

  • Nephrology
  • Cardiovascular Research
  • Translational Medicine

Background:

  • Renin-angiotensin system activation is linked to hypertension and chronic kidney disease (CKD).
  • Existing hypertension-induced CKD mouse models do not accurately reflect human disease progression.
  • A need exists for a mouse model to study the pathogenesis of progressive renal disease.

Purpose of the Study:

  • To investigate if renin-overexpressing mice (RenTg) replicate the kinetics and pathology of hypertension-induced renal disease.
  • To identify cellular and molecular events in CKD progression using the RenTg model.

Main Methods:

  • Utilized a novel transgenic RenTg mouse strain with a clamped renin transgene.
  • Monitored hypertensive and albuminuric status, renal vascular markers, immune cell infiltration, and gene expression over 12 months.
  • Assessed structural renal alterations characteristic of hypertensive renal disease.

Main Results:

  • RenTg mice exhibited progressive hypertension and albuminuria starting at 3 months.
  • Early signs included increased adhesion molecules (VCAM-1, PECAM-1) indicating endothelial dysfunction.
  • Later stages (8-12 months) showed macrophage infiltration, nephrin downregulation, KIM-1 upregulation, pro-fibrotic factor increase, and structural damage (glomerular ischemia, sclerosis, mesangial expansion, tubular dilation).

Conclusions:

  • The RenTg mouse strain provides a progressive model for studying hypertension-induced CKD.
  • Endothelial dysfunction is an early pathogenic event preceding structural and fibrotic changes in this model.
  • This model offers new insights into CKD mechanisms and potential therapeutic targets for renal failure.

Related Concept Videos